Oct 082020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, NJ –  Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases, today announced the appointment of Board member, Dr. Ali Behbahani, as Board Chair effective immediately, succeeding Dr. Michael Ackermann, who ...

Oyster Point Pharma appoints Dr. Ali Behbahani as Board chairman alongside Michael Atieh joining as new Board member

Oyster Point Pharma appoints Dr. Ali Behbahani as Board chairman alongside Michael Atieh joining as new Board member

From:: Oyster Point Pharma appoints Dr. Ali Behbahani as Board chairman alongside Michael Atieh joining as new Board member

Sorry, the comment form is closed at this time.